Physician profile
Fred Cunningham
NPI 1528038312
$10,645.94
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,274 · 2021: $1,294 · 2022: $38.86 · 2023: $38.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $5,089.27 | 2019-2021 | |
| Spinesmith Holdings, LLC | $4,200.00 | 2019 | |
| Medinc of Texas | $1,200.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $64.34 | 2019-2023 | |
| Relievant Medsystems, INC. | $38.86 | 2022 | |
| Smith+Nephew, INC. | $14.74 | 2021 | |
| Depuy Synthes Sales INC. | $14.07 | 2019 | |
| Vericel Corporation | $12.42 | 2019 | |
| Orthofix Medical, INC. | $12.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.